R&D/ Views & Analysis/ Views and analysis A bright future for CNS and Alzheimer’s? George Underwood Alzheimer's, amyloid, Asceneuron, CNS, progressive supranuclear palsy, Tau 0 Comment Swiss biotech Asceneuron is developing what could be the first treatment for progressive supranuclear palsy (PSP), a rare Share X A bright future for CNS and Alzheimer’s? https://pharmaphorum.com/r-d/views-analysis-r-d/a-bright-future-for-cns-and-alzheimers/
Alzheimer's, amyloid, Asceneuron, CNS, progressive supranuclear palsy, Tau
0 Comment
